|
BRPF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7921999999948E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.10579999999827E-05 |
| Normal-vs-Stage2 |
1.226550E-01 |
| Normal-vs-Stage3 |
5.65949999999926E-05 |
| Normal-vs-Stage4 |
2.844000E-04 |
| Stage1-vs-Stage2 |
1.522840E-01 |
| Stage1-vs-Stage3 |
2.269000E-01 |
| Stage1-vs-Stage4 |
3.868400E-01 |
| Stage2-vs-Stage3 |
3.779700E-02 |
| Stage2-vs-Stage4 |
6.702100E-02 |
| Stage3-vs-Stage4 |
9.389800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58553999999311E-05 |
| Normal-vs-AfricanAmerican |
8.992000E-02 |
| Normal-vs-Asian |
4.859400E-03 |
| Caucasian-vs-AfricanAmerican |
3.316600E-01 |
| Caucasian-vs-Asian |
6.269000E-01 |
| AfricanAmerican-vs-Asian |
5.836600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.275650E-03 |
| Normal-vs-Female |
1.52217999999094E-05 |
| Male-vs-Female |
3.865800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.552370E-04 |
| Normal-vs-Age(41-60Yrs) |
1.990410E-04 |
| Normal-vs-Age(61-80Yrs) |
6.990100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.046100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.365000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.773800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.888000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.710200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.285000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.156400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.153420E-04 |
| Classical-VS-Follicular |
9.403200E-01 |
| Classical-VS-Other |
6.781400E-01 |
| Classical-VS-Normal |
1.801140E-03 |
| Tall-VS-Follicular |
1.756740E-03 |
| Tall-VS-Other |
1.579640E-01 |
| Tall-VS-Normal |
1.8830000003689E-07 |
| Follicular-VS-Other |
7.402600E-01 |
| Follicular-VS-Normal |
4.824200E-03 |
| Other-VS-Normal |
1.114030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.830880E-04 |
| Normal-vs-N1 |
4.179600E-04 |
| N0-vs-N1 |
2.397800E-01 |
|
|
